[pending] DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)
Pending LLM rewrite. Source: FDA_DRUG D-0510-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
The recalled product
- Product
- DESMOPRESSIN ACETATE (DESMOPRESSIN ACETATE)
- Brand
- DESMOPRESSIN ACETATE
- Manufacturer
- Apotex Corp.
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: VM4231
- Exp 06/30/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · DESMOPRESSIN ACETATE
- HighFDA recalls prescription desmopressin acetate tablets for subpotency
FDA (Drugs) · 2022-12-07
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereChloraPrep One-Step Antiseptic Applicators recalled for lack of sterility assurance
FDA (Drugs) · 2026-07-08
- SevereAccucaine Lidocaine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Sterile Solution Lacks Assurance of Sterility
FDA (Drugs) · 2026-07-08
- ModerateMedline Ophthalmic Pack with Lidocaine Injection Kits Recalled
FDA (Devices) · 2026-07-08